Planned Parenthood has won a partial victory in a legal fight with President Donald Trump’s administration over its efforts ...

Patents are a mutually beneficial agreement between inventors and the government. Each side makes concessions in service of their own, and ...

This month in the Zantac litigation, the Delaware Supreme Court tossed all the plaintiffs’ experts in thousands of cases, ...

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...

Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX), its partner for the Comirnaty COVID-19 vaccine, made legal submissions to ...

Pfizer's revenue slump is temporary. New launches and Seagen integration drive 2025 growth. Read here for an investment analysis of PFE stock.

Pfizer CEO Albert Bourla, Ph.D., has pulled back the curtain on his $1.25 billion bet on a PD-1xVEGF bispecific, revealing that his team went through individual scans and interviewed investigators ...

Pfizer is in-licensing a bispecific antibody drug for cancer that China-based 3SBio designed to block the proteins PD-1 and VEGF. The deal puts the pharmaceutical giant in a growing group of ...

Kansas Attorney General Kris Kobach sued Pfizer over its marketing of the COVID-19 vaccine. A federal judge sent the case back to state court.

Pfizer will continue operating in Lee County after consolidating facilities. The move comes 18 months after Pfizer confirmed it would close two Triangle sites.

A case against one of the major COVID-19 vaccine providers filed by the Kansas Attorney General will be heard at the state level following a move by a federal judge.